Top Stories News
Top Stories news
-
News IMI Announces 23 Unique Projects to Boost Drug Innovation
The IMI launches its second wave of research projects including cancer, immune-mediated diseases, infectious disorders and electronic health. -
News EU Opens Antitrust Investigation Assessing Deal between Cephalon and Teva
The European Commission has launched a formal antitrust investigation to assess an agreement between Cephalon and Teva. -
News Amylin Sues Lilly over Sales Deal
Drugmaker Amylin said it is suing Eli Lilly, alleging Lilly violated their alliance by teaming up with Boehringer Ingelheim. -
News India in Talks with EU to Ease Restrictions on Ayurveda Drugs
According to the ban came into force from May 1, a company needs to demonstrate its efficacy and safety through traditional use for at least 30 years of which 15 years should be within EU. The new guideline mandates registration of a herbal medicine. -
News Astellas & BioFocus Ink Target Discovery Deal
BioFocus has signed a collaboration agreement with Tokyo-based Astellas Pharma focused on discovering novel targets in the field of CNS disorders. -
News EMD Millipore Opens Biopharmaceutical Technical Center in Shanghai
The facility will provide support, training and validation services to EMD Millipores biopharma customers with operations in China. -
News ICON & Boston Research Institute Form Alliance
The alliance will combine BCRIs leadership in clinical strategy, study planning and academic relationships with ICONs experience in the execution of global clinical trials. -
News Swiss Approves Novartis Votubia Tablets for SEGA
The drug is the first to be approved in Switzerland for treating subependymal giant cell astrocytoma (SEGA). -
News Onyx Scientific Wins Phase I API Contract
Cancer Research UK has selected the UK-based API manufacturer to develop the chemistry and perform the GMP synthesis of the API for use in a Phase 1 clinical trial. -
News Immunologix & DavosPharma Form Marketing Alliance
The partnership allows both parties to offer their clients a platform to 100% human monoclonal antibody ready for clinical trials. -
News Sanofi-Aventis Changes Name to Sanofi
French pharmaceutical group Sanofi-Aventis has abandoned its double-barreled name it acquired along with Aventis in 2004. -
News Alkermes to Merge With Elan Drug Technologies
Alkermes Inc. said Monday it will merge with Elan Drug Technologies in a cash-and-stock deal valued at $960 million. -
News J&J Files New Concerta Lawsuit Against Impax Labs
Impax said the lawsuit alleges its generic violates patents belonging to Alza supporting Concerta tablets of 18 milligrams, 27 milligrams and 36 milligrams. -
News Quotient Clinical Completes Expansion in UK
The new facilities have been inspected and approved for use by the UK regulatory authority and have been awarded Supplementary Accreditation. -
News Bristol-Myers Squibb Recalls Coumadin Tablets
Bristol-Myers Squibb has initiated a voluntary recall of Coumadin crystalline 5mg tablets used to treat or prevent blood clots. -
News INC Research Acquires Kendle for $232M
INC Research has inked a $232 million deal to acquire Kendle, a publicly traded company based in Cincinnati that ranks among the top 10 contract research organizations. -
News SCM Pharma Gets Aseptic Fill Project
UK-based contract manufacturing organisation SCM has secured a sterile filling and packaging project with Italian Molteni Therapeutics. -
News Merck Serono Settles Prescription Lawsuit
Under the terms of the settlement, Merck Serono will pay $44.3m to the US government. -
News Indian Biotech Industry to Hit $10B in 2015
India's biotech industry is expected to swell to $10 billion in 2015. -
News Oxford Biomedica Inks Antibody Deal with Pfizer
Oxford BioMedica has expanded its 5T4 tumor antigen therapeutics collaboration with Pfizer. -
News Officials Meet for Pharma Trade between Argentina and India
Argentina has assured India that it would solve the issue of restrictions on finished pharmaceutical products from India to Argentina. -
News Global Orthopedics Industry Approached $30B in 2010
The global orthopedics industry has an annual growth rate of about 5% to 7% and approached $30 billion in 2010. -
News Akorn To Acquire AVR for Eye Care Market
Akorn Inc. said it will buy Massachusetts ophthalmic company Advanced Vision Research Inc. for $26 million. -
News Dipharma Receives Favourable Court Decision Regarding Generic Allegra®
The U.S. District Court for the District of New Jersey issued a judgment in its favor concerning its litigation over Dipharma's manufacture and sale of Fexofenadine HCl. -
News Teva to Acquire Cephalon for $6.8 Billion
The combined company will have complementary commercial, R&D and operational capabilities and will provide a broad spectrum of specialty branded products. -
News Grifols & Talecris Sign Consent Agreement for Merger
Grifols has agreed to the sale of select assets and has entered into certain commercial, lease and manufacturing agreements with the Italian company Kedrion for as many as seven years. -
News FDA & IPEC Work on Excipient Screening
The screening programme is to improve the efficiency of the FDA's monitoring and surveillance of the pharmaceutical supply chain. -
News Althea and Biotest Establish Commercial Filling Agreement
Under the terms of the agreement, Althea will fill commercial drug products to supply the U.S. market. -
News Nautic Buys Omnicare Clinical Research
Omnicare Clinical Research has been acquired by Nautic Partners, LLC, a private equity firm based in Providence, R.I. -
News CIT Acquires LAB Research
The new CIT-LAB group will have consolidated sales of $103 million and 830 staff across five sites in France, Canada, Denmark and Hungary. -
News RxTrials & Integra Announce Strategic Partnership
Under the agreement, Integra will become an RxTrials partner research site and the partnership will enhance their collective capacity to conduct industry-sponsored clinical research. -
News J&J & Synthes Ink $21.3B Deal
J&J will merge Synthes with its DePuy operations, creating an organization that would own nearly 28 percent of the orthopedic device market. -
News Inovio, Transgene and ChronTech Collaborate for HCV Vaccine
Each partner will contribute its products and equally share costs related to the study. -
News Lilly & Medtronic Team up on Parkinson's Treatment
Medtronic Inc. said Tuesday that it is working with Eli Lilly & Co. on a treatment for Parkinson's disease. -
News Akebia Completes $22M Series B Financing
Akebia announced that it has closed a Series B financing totaling $22 million. -
News FDA Extends Sanofi Pasteur Menactra Use
The approval was based on results from a Phase II trial and three Phase III trials in more than 3,300 infants that received Menactra vaccine using a two-dose schedule. -
News Bayer & OncoMed Sign Clinical Mfg Deal
Bayer will manufacture the bulk drug substance at its Berkeley, CA clinical manufacturing center to support Phase I testing, which expected to begin in 2012. -
News FDA: Highly Anticipated Merck Drug Eliminated Traces of Hepatitis C
FDA officials say a highly-anticipated drug to treat hepatitis C made by Merck appears to cure more patients in less time than established drugs. -
News Mylan Launches First Generic Version of Femara Tablets
Generic drugmaker Mylan Inc. said Monday it has launched a generic version of Novartis' breast cancer treatment Femara. -
News Unused and Expired Prescription Drugs Pose Safety Threats
According to a national survey, more Americans currently abuse prescription drugs than the number of those using cocaine, hallucinogens, and heroin combined. -
News Mochida Receives Approval of Lexapro in Japan
The launch of Lexapro? will be supported by more than 2,000 sales representatives, which is fully competitive in the Japanese market. -
News Australia Sees A Gap in Cancers Represented in Clinical Trials
Four of the five cancers that result in the greatest burden of disease had relatively few clinical trials: lung, colorectal, prostate and pancreatic cancers. -
News Luitpold Pharmaceuticals, Inc. Announces Temporary Suspension of Distribution and Manufacture of Drug Products
As a result of a recent inspection and a follow-up meeting with FDA, Luitpold agreed to suspend distribution of any drug product manufactured at its Shirley, New York facility. -
News ICON & ACRONET Sign Alliance in Japan
Through the agreement, ICON and ACRONET will collaborate to offer global and Japanese pharmaceutical clients a full range of clinical development capabilities. -
News Amgen Outlines Strategy and Capital Allocation Plans
Amgen has outlined its strategy, capital allocation plans and provided financial guidance for 2015 during a meeting with investors this week. -
News Two Plants Fall to GSK Strategy Shift
The sale of two manufacturing plants in Memphis and Aiken leads to the potential loss of 460 manufacturing jobs. -
News Gilead & MicroDose Ink RSV Deal
Gilead Sciences said Wednesday it signed a licensing deal with MicroDose Therapeutx for an experimental respiratory syncytial virus treatment. -
News Actavis Produces 10 Million Tablets for Japan
The tremendous earthquake in Japan damaged the production plant of Aska, which is a joint venture partner of Actavis. This left Japan with a potential supply shortage of Levothyroxine. -
News EU Gives Consortium $1.6M for Ultrasound-triggered Drug Delivery
The EU has awarded about $1.6 million to a consortium of companies developing an ultrasound-triggered drug-delivery technology. -
News Pfizer & Shanghai Pharmaceutical Sign Partnership Memorandum
The companies plan to explore future cooperation opportunities, including further distribution and commercialization, research and development activities, manufacturing and equity investment opportunities. -
News Debiopharm and Aurigene to Develop Oncology Drug
The Debio 1142 project aims to develop inhibitors that target this oncology pathway, which plays key roles in various solid tumours. -
News Evotec Completes Acquisition of Kinaxo
With the acquisition of Kinaxo, Evotec is expanding its drug discovery platform with cutting-edge technologies. -
News Novartis Withdraws Marketing Authorization Application for Joicela
The company stated its decision was based on its inability to address the CHMPs request to provide additional data within the timeframe allowed in the centralised procedure. -
News SciClone Acquires China-based Specialty Pharma
SciClone Pharmaceuticals Inc. bought NovaMed Pharmaceuticals Inc., a Chinese specialty pharmaceutical company, in a cash and stock deal worth up to nearly $105 million. -
News Baxter To Acquire Prism for $338M
Baxter International Inc. said Monday it will acquire privately-held Prism Pharmaceuticals, Inc. for a total consideration of up to $338 million. -
News CROM Acquires MSOURCE for New CRO
The new CRO company will employ about 400 employees and generate over 50 Mio Euros of revenues. -
News Regulus and US University to Develop Treatments for Angiogenic Diseases
Regulus Therapeutics is working with researchers from university to identify new microRNA therapeutics for the treatment of angiogenic diseases. -
News GSK To Shed Non-core OTC Products
GSK will divest non-core OTC brands for its Consumer Healthcare business around a portfolio of priority brands and emerging markets. -
News Merck and J&J Settle Rights Dispute
Merck and Johnson & Johnson have finally reached a settlement in their dispute over the distribution rights for Remicade and Simponi. -
News Bayer's Rivaroxaban Submitted for Approval in Japan
Bayer has submitted its rivaroxaban to the Japanese Ministry of Health, Labor and Welfare for marketing approval in the prevention of stroke in patients with atrial fibrillation. -
News Nycomed Gets Distribution Rights to Product Portfolio in Turkey
Nycomed replaces the specialty pharmaceutical company Biomeks ?la? (Biomeks) as the marketing authorization holder and distributor for the majority of Biomeks' product portfolio in Turkey. -
News Lilly & Amylin Receive EU Recommendation for Bydureon
Bydureon, a long-acting form of the daily drug Byetta, has received EU recommendation which is very important for Eli Lilly and Amylin. -
News Merrimack Raises $77M to Develop Cancer Drug
Merrimack Pharmaceuticals Inc., a company developing cancer drugs, said it has raised $77 million in a private financing round. -
News Taris Biomedical Raises $18.3M for Bladder Drug Delivery
The investment will advance the company's lead product candidate, Lidocaine Releasing Intravesical System (LiRIS), into later stage clinical development. -
News J&J Unit Recalls Topamax Lots Over Smell
A division of Johnson & Johnson recalls approximately 57,000 bottles of Topamax after reports of an uncharacteristic odor. -
News Axcan Acquires Mpex Pharma
Privately-held specialty pharma Axcan will buy Mpex Pharmaceuticals to obtain the latter's Phase III-stage Aeroquin therapy. -
News Orasi & Biogen Sign Biomarker Technology Deal
Orasi Medical announced yesterday that the company has entered into an agreement with Biogen Idec to test novel biomarkers in the development of treatments for central nervous system disorders. -
News Pieris Inks 207M Discovery Deal with Daiichi Sankyo
The companies signed a collaboration and license agreement under which Pieris will use its Anticalin scaffold technology against two targets to be provided by Daiichi Sankyo. -
News Roche & Lonza Ink Assay Distribution Deal
The internal integration of user and manufacturer helps ensure products align properly with user requirements and capabilities. -
News American Red Cross Donations to Japanese Red Cross Reach $100 Million
An additional commitment of $40 million dollars to the Japanese Red Cross brings the total contributions of the American Red Cross to $100 million. -
News Amgen Buys Brazilian Pharma
Amgen has expanded its operations into Brazil with the acquisition of Bergamo, a privately held Brazilian pharmaceutical company, for approximately $215 million. -
News Merger of Alcon into Novartis Approved by Shareholders
The companies plan to proceed quickly with the transaction close to begin integration of the businesses and establishing a globally leading eye care business. -
News AMRI and Parnell Ink Development and Supply Deal
AMRI announced that it has entered into a development and commercial supply agreement with Parnell. -
News WHO Warns of Loss of Essential Medicines
The WHO said generations of drugs are under threat as microorganisms are becoming increasingly resistant to them. -
News Analyst: J&J May Need A $10B-plus Deal
The company may look at deals worth more than $10 billion to compensate for a lack of organic growth and to provide an outlet for its steady buildup of cash. -
News Lupin & Salix Expand Rifaximin Pact
Lupin will receive a $10 million up-front payment as well as potential U.S. regulatory milestones for products covered by Lupin patents or jointly held patents. -
News Optimer & Cubist Ink Dificid Co-promotion Deal
Optimer will be responsible for the manufacturing and distribution of Dificid in the U.S. and for recording product revenue. -
News Merck & Roche Use Voice-enabled Tech for Pick Operations
The need for such voice system arose when constant use of a barcode reader slowed picking. -
News Dipharma Receives Favourable Court Decision Regarding Generic Allegra®
The U.S. District Court for the District of New Jersey issued a judgment in its favor concerning its litigation over Dipharma's manufacture and sale of Fexofenadine HCl. -
News Merck To Acquire Inspire
Merck says it is buying Inspire Pharmaceuticals for about $430 million to expand its product portfolio with treatments for eye conditions. -
News EAG Acquires Chemir Analytical Services
Evans Analytical Group, Inc. announced that it has acquired Chemir Analytical Services and its affiliates CAS-MI Laboratories and Cyanta Analytical Services. -
News GSK & Pfizer Pay $262M to U.S. Doctors
Pfizer paid $177 million and GlaxoSmithKline PLC paid $85 million during 2010 to U.S. doctors and institutions for their work on clinical trials, consulting, speaking and other items. -
News BARDA Grants Biota $231 Flu Vaccine Contract
BARDA is giving $231 million to Australia-based Biota for the company's flu treatment laninamivir. -
News Invida & Roche Ink Pact for Portfolio in Korea
Roche Korea has restructured for 2011 as part of its recently announced Operational Excellence Program. -
News Morning-After Pill Made Free in Welsh Pharmacies
Pharmacies in Wales are handing out emergency contraception free of charge to under 16s. The move has caused controversy in the UK. -
News Acacia Pharma Rounds up $10M in Series A
The UK's Acacia Pharma raised $10 million in its Series A financing. -
News Isogenica Sets Up North American Office
Isogenica announced that it has established a dedicated business development and customer support team based in Alameda, California. -
News ICON Opens Shanghai Office
ICON has established a new office in Shanghai to expand its business in the Asia-Pacific region. -
News Ecron Acunova Acquires aCROnordic
Ecron Acunova has acquired a full service CRO to expand its clinical research presence in north Europe region. -
News New Measures to Boost UK Pharma Innovation
New measures in the budget have been made to benefit pharma industry in the UK including an additional ?100m for science innovation facilities. -
News Cannabis-Based Eye Drug Approved in Six European Countries
A cannabis-based oromucosal spray for the treatment of spasticity will be launched in six European countries. -
News Sanofi Signs Diabetes Research Pact
The three-year research collaboration will investigate the role of the osteoblast-secreted peptide, osteocalcin, in diabetes management. -
News CPHI Buyers Sourcing Event Starts Registration
Organized by CPHI.cn & CPHI-online.com, the first Buyers Sourcing Event will be held on 21st-23rd June, concurrently with CPHI China Expo 2011. If you have purchase demands, please contact us on 0086-400-610-1188 or visit http://www.cphi-online.com/sou... -
News DSM Transforms Focus on Future
DSMs new strategy is to respond to key trends in an effort to support its customers in developing solutions that meet current and future needs. -
News MG America Named Exclusive North American Distributor
Based in Parma, Italy, GF S.p.A offers production programs for both aseptic and multifunction filling, as well as inspection machines and a range of products for varying filling needs. -
News Pozen Inks Deal With J&J Company for Migraine Drug
Drug developer Pozen said the deal marks the first step in bringing its treatment to migraine patients living outside the United States. -
News Cephalon To Acquire Gemin X
Cephalon has signed a contract to acquire Gemin X Pharmaceuticals. The merge is expected to close in 2Q11. -
News Merck & Sanofi End Animal Health JV
The two firms have mutually agreed that ending the agreement is in the best interests of both companies. There are no associated termination penalties and each company is responsible for its own expenses. -
News Gerresheimer Acquires Brazilian Manufacturer
A Sao Paolo-based manufacturer of plastic pharmaceutical packaging products has been acquired by Gerresheimer AG for the development of packaging business in South America. -
News Almac & Exco InTouch Form Technology Alliance
The alliance between Almac and Exco InTouch provides sponsors with a practical, cost-effective solution to managing patients during a clinical trial. -
News Tekmira Sues RNAi Drug-delivery Partner Alnylam
The Tekmira-Alnylam fight highlights the current research efforts to overcome the challenge of delivering RNAi drugs into cells before they are damaged in the bloodstream or cause certain immune reactions. -
News Industry Lobbies for Foreign Plant Inspections
Two industry groups with skin in the game say they want foreign API plants inspected by the FDA. And they're willing to pay for it. -
News Quest To Acquire Celera for $671M
Quest Diagnostics agreed Friday to acquire Celera Corp. as the company seeks to expand in gene-based medical testing. -
News Sage Bionetworks and AZ Sign Cancer Deal
Bionetworks and AstraZeneca have initiated a collaboration to make new insights into some cancers using advanced computational models of disease genetics. -
News Ambrilia & ZBx Ink Licensing Deal
Ambrilia and ZBx has entered into an exclusive license option agreement for the worldwide rights to Ambrilia's PSP-94 technology for prostate cancer diagnosis. -
News Anacor Signs Deal with MMV for Malaria Treatment
Anacor announced its development agreement with Medicines for Malaria Venture to develop a treatment of malaria. -
News Japanese Pharma Association Opens Relief Headquarters for Quake Victims
The emergency relief headquarters will deliver ethical drugs to help the people affected by the earthquake. -
News GSK Supports Recovery Efforts to Help Quake Victims
GSK is practicing its disaster relief program for the quake victims in Japan. -
News Daiichi Recalls Sanofi ActHIB Vax in Japan
Daiichi Sankyo will recall 13 lots in Japan of a Sanofi Pasteur ActHIB vaccine due to an unidentified substance found in two syringes. -
News Mylan Drugs Recalled on Mixed-up Labels
Mylan said that its internal investigation found that labels for Mylan-Amlodipine were mixed together with labels for Mylan-Minocycline. The recall affects one lot of the meds. -
News Epistem & Sanofi Enter Research Pact
The collaboration is expected to establish a biomarker strategy aimed at identifying biological responses to drugs in relevant tissues. -
News India Signs Pharma Deal with Nigeria
India and Nigeria have signed an agreement to cooperate in the pharmaceutical sector. -
News Pharma Firms Aid to Japan Continues
Donations from pharmaceutical companies are being provided to help the victims in Japan. -
News R&D Investment by U.S. Biopharma Firms Reached Record Levels in 2010
Among PhRMA member companies, more than 75 percent of research dollars were invested in the U.S. -
News EMA & FDA Team on QbD Parallel Evaluation Pilot Scheme
The EMA and the US FDA will conduct parallel assessment of QbD development and manufacturing data for new drug submissions. -
News Cytovance Secured $22.5M for Bio-Manufacturing Capabilities
The investment will enable Cytovance to expand its clinical trial and commercial scale cGMP manufacturing by funding facility, service and personnel expansion at its research and manufacturing operation. -
News Japan Hands Out Cancer Drugs as Radiation Risk Grows
Japan is handing out iodine pills to prevent the risk of thyroid cancer as the danger of nuclear radiation increases. -
News FDA Scolds SCOLR for Deficient ANDA Filing
SCOLR Pharma has received a letter from the FDA identifying deficiencies regarding its Abbreviated New Drug Application for extended-release pseudoephedrine. -
News Roche & Novartis Make MIT Innovators List
Nine life science companies have made the list of the top 50 innovators. -
News Overseas Manufacturing Puts U.S. at Risk
More drugs approved in the U.S. are manufactured overseas. This makes FDA inspection rate drop.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance